Everyway Facial MENS

K142794 · Everyway Medical Instruments Co.,Ltd · NFO · Jun 2, 2015 · Neurology

Device Facts

• Record ID: K142794
• Device Name: Everyway Facial MENS
• Applicant: Everyway Medical Instruments Co.,Ltd
• Product Code: NFO · Neurology
• Decision Date: Jun 2, 2015
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 882.5890
• Device Class: Class 2
• Attributes: Therapeutic

Indications for Use

The Everyway Facial MENS, model: MT-200 is intended for facial stimulation and indicated for over-the-counter cosmetic use.

Device Story

Single-channel transcutaneous electrical nerve stimulator (TENS) for facial stimulation; OTC cosmetic use. Device consists of thermoplastic resin housing with two fixed stainless steel hemispherical probes. Powered by 9V battery. User operates via intensity control knob; green LED indicates operation. Probes glide over skin to deliver low-level electrical impulses; requires conductive derma gel. Device alternates positive/negative polarity between probes. Output amplitude adjustable 0-400 microamp (up to 3mA load). Provides personalized comfort levels for facial stimulation. Safety features include automatic overload, no-load trip, and automatic shut-off.

Clinical Evidence

No clinical data; bench testing only. Safety and performance verified through compliance with IEC 60601-1, IEC 60601-1-2, and IEC 60601-2-10 standards, plus software verification per FDA guidance.

Technological Characteristics

Thermoplastic resin housing; stainless steel hemispherical probes (25mm diameter). Energy source: 9V battery. Output: Biphasic rectangular waveform; 8-10Hz frequency. Connectivity: Standalone. Software: Microprocessor-controlled with automatic safety trips (overload, no-load, shut-off). Sterilization: Not specified.

Indications for Use

Indicated for over-the-counter cosmetic facial stimulation.

Regulatory Classification

Identification

A transcutaneous electrical nerve stimulator for pain relief is a device used to apply an electrical current to electrodes on a patient's skin to treat pain.

Predicate Devices

• NuFace® Facial Toning Device (K072260)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized image of three human profiles facing right, stacked on top of each other. The profiles are connected and appear to be part of a single, flowing design. The profiles are surrounded by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

June 2, 2015

Everyway Medical Instruments Co., Ltd. Robert Tu 3FL., No 5, Lane 155, Section 3 Peishen Rd. Shen Keng Hsiang, Taipei Hsien Taiwan, 222, ROC

Re: K142794

Trade/Device Name: Everyway Facial MENS, model MT-200 Regulation Number: 21 CFR 882.5890 Regulation Name: Transcutaneous electrical nerve stimulator for pain relief Regulatory Class: Class II Product Code: NFO Dated: May 1, 2015 Received: May 4, 2015

Dear Mr. Tu:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21

{1}------------------------------------------------

CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

for

Sincerely yours.

Felipe Aquel - S

Carlos L. Peña, PhD, MS Director Division of Neurological and Physical Medicine Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

### Indications for Use

510(k) Number (if known) K142794

#### Device Name

Everyway Facial MENS, model: MT-200

Indications for Use (Describe)

The Everyway Facial MENS, model: MT-200 is intended for facial stimulation and indicated for over-the-counter cosmetic use.

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)

|X | Over-The-Counter Use (21 CFR 801 Subpart C)

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail]

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

3F1., No. 5, Lane 155, Sec. 3,Peishen Rd, Shen Keng Hsiang, Taipei Hsien, Taiwan,

## 510(K) SUMMARY

This summary of 510(k) safety and effectiveness information is being prepared in accordance with the requirements of SMDA 1990 and 21 CFR 807.92 at June 15, 2011.

The assigned 510(k) number is: K142794 .

- 1. Submitter's Identifications:
Establishment: EVERYWAY MEDICAL INSTRUMENT CO., LTD. Address: 3Fl., No. 5, Lane 155, Sec. 3, Peishen Rd., Shenkeng Hsiang, Taipei Hsien 222, Taiwan Registration Number: 9616877 Operations: Manufacturer

Owner/Operator:EVERYWAY MEDICAL INSTRUMENT CO., LTD. Address : 3Fl., No. 5, Lane 155, Sec. 3, Peishen Rd., Shenkeng Hsiang, Taipei Hsien 222, Taiwan Contact Person: Robert Tu Phone : [phone] Fax No: 886-2-2664-5566 e-mail : [e-mail]

- 2. Name of the Device: Everyway Facial MENS/ Model: MT-200.
- 3. Information of the 510(k) Cleared Device (Predicate Device): K072260: NuFace® Facial Toning Device.
- 4. Classification Information: Trade/Device Name: Everyway Facial MENS/ Model: MT-200. Requlation Number: 21 CFR 882.5890 Classification Name: Stimulator, Nerve, Transcutaneous For Pain Relief. Regulatory Class: II Product Code: NFO
- 5. Device Description:

The Everyway Facial MENS, model MT-200 is a single channel transcutaneous electrical nerve stimulator intended for facial stimulation by applying an electrical current to electrodes, which are attached on the user's skin.

The device measures 95mm(H)x23.5mm (T). Its outer housing is made of injection molded thermoplastic resin with the output contact probes consist of chrome-plated spheres. The device is powered by a 9-Volt battery to generate microcurrent that is discharged through the two fixed smooth spherical probes.

The device is operated in such a way that turn on the intensity control knob and adjust the intended intensity or turn off the device during operation through the same control knob. While device is turned on for operation, a green LED will then illuminate indicating the device is in operation condition. User then follow the instruction for use to get appropriate stimulation treatment. The two probes gently glide over the skin to deliver low-level electrical impulses to strategic location on the face as his intension.

{4}------------------------------------------------

3F1., No. 5, Lane 155, Sec. 3,Peishen Rd, Shen Keng Hsiang, Taipei Hsien, Taiwan,

The probes of Evweyway Facial MENS, model MT-200 are designed for optimal contact with the face. The MT-200 device continually alternates the positive and negative polarity between the two output spherical probes through the internal control circuit of the device and the pulse rate set by user. The MT-200 also allows user to adjust setting output amplitude from 0 to 400 microamp for a personalized comfort level. The MT-200 device requires the use of conductive derma gel provided together with the device. With the combination of the main device parts as above mentioned, the device can be used as recommended in manual for facial stimulation and indicated for over-the-counter cosmetic use.

#### 6. Intended Use:

The Everyway Facial MENS, model: MT-200 is intended for facial stimulation and indicated for over-the-counter cosmetic use.

#### 7. Comparison to the 510(k) Cleared Device (Predicate Device):

| The following features are completely identical among the predicate device and our device | | |
|-------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------|
| Features | 510(K) Proposed Model | New Model |
| Model Name | NuFaceR Facial Toning Device | Everyway Facial MENS, model MT-200 |
| 510(K) No. | K072260 | K142794 |
| Prescription or OTC | OTC | OTC |
| FDA product code | NFO | NFO |
| Indication for Use | intended for facial stimulation and indicated<br>for over-the-counter cosmetic use. | intended for facial stimulation and indicated<br>for over-the-counter cosmetic use. |
| Electrode Used | Dual contact probes consist of<br>chrome-plated spheres with diameter 30<br>mm.<br>Note: Surface is 28.3cm²/ Per contact<br>probe | Dual contact probes consist of stainless<br>steel hemispheres with diameter 25mm.<br>Note: Surface is 9.8cm²/ Per contact<br>probe |

#### 8. Significant output characteristics comparison table:

| Parameter | | Predicate Device | New Device |
|-------------------------------------------------------------------------------------------------|--------------------------------|------------------------------|-------------------------------|
| 510(K) Number | | K072260 | K142794 |
| Device Name and Model | | NuFaceR Facial Toning Device | MT-200<br>Facial MENS |
| Manufacturer | | Carol Cole | Everyway |
| Power Source(s) | | 9 Vx1 | 9 Vx1 |
| - Method of Line current Isolation | | Type BF | Type BF |
| - Patient Leakage Current | | --- | --- |
| - Normal condition (uA) | | Under 0.1 | Under 0.1 |
| - single Fault condition (uA) | | Under 0.5 | Under 0.5 |
| Average DC current through electrodes when<br>device is on but no pulses are being applied (uA) | | Not applicable | Not applicable |
| Number of Output Modes | | 1 (8~10Hz) | 3 (8Hz, 9Hz, 10Hz) |
| Number of Output<br>Channels: | Synchronous or<br>Alternating? | Alternating | Alternating |
| | Method of Channel<br>Isolation | Output Coil | Output Coil |
| Regulated Current or Regulated Voltage? | | 0-400uA | 0-3mA (load 4kΩ) |
| Software/Firmware/Microprocessor control? | | Yes | Yes |
| Automatic Overload Trip? | | Yes | Yes |
| Automatic No-Load Trip? | | Yes | Yes |
| Automatic Shut Off? | | Yes | Yes |
| User Override control? | | Yes | Yes |
| Indicator Display: | On/Off Status? | Yes | Yes |
| | Low Battery? | Yes | Yes |
| | Voltage/Current<br>Level? | Yes | Yes |
| Timer Range (Minutes) | | Continuous | 20, 40 minutes and Continuous |
| Compliance with Voluntary Standards? | | IEC 60601-2-10 | IEC 60601-2-10 |
| Compliance with 21 CFR 898? | | Yes | Yes |
| Weight (g) including battery | | 817 g | 115 g |
| Dimensions (mm.) [W x H x D] | | 63.5X177.8X25.4 mm | 65X95X23.5 |
| Housing Materials and construction | | ABS | ABS |

{5}------------------------------------------------

3F1., No. 5, Lane 155, Sec. 3,Peishen Rd, Shen Keng Hsiang, Taipei Hsien, Taiwan,

### For the device output features, we also provided the comparison for the output characteristics as the following table:

| Parameter | | Predicate Device | New Device |
|-------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------|-----------------------------------------------|---------------------------------------------|
| Mode or Program Name | | NuFace® Facial Toning Device | MT-200<br>Facial MENS |
| Waveform (e.g., pulsed monophasic, biphasic) | | Biphasic | Biphasic |
| Shape (e.g., rectangular, spike, rectified<br>sinusoidal) | | Rectangular | Rectangular |
| Maximum Output Voltage (volts)<br>(+/- 20 %) | | 0.336V @500Ω<br>1.14V @2KΩ<br>5.68V @10KΩ | 1.78V @500Ω<br>6.64V @2KΩ<br>16.2V @10KΩ |
| Maximum Output Current (mA)<br>(+/-_20 %) | | 0.672mA @500Ω<br>0.57mA @2KΩ<br>0.568mA @10KΩ | 3.56mA @500Ω<br>3.32mA @2KΩ<br>1.62mA @10KΩ |
| Duration of primary phase (mSec) | | ~108mS | ~99-125mS (Burst) |
| Pulse Duration (mSec) | | ~54mS | ~49-63mS |
| Frequency (Hz) [or Rate (pps)] | | 8~10Hz | 8Hz, 9Hz, 10Hz |
| For<br>multiphasic<br>waveforms<br>only: | Symmetrical phases? | Yes | Yes |
| | Phase Duration (include units),<br>(Stage range, if applicable), | pulsed monophasic<br>Positive:~54mS | pulsed monophasic<br>Positive:~49-63mS |
| | (both phases, if asymmetrical) | Negative: ~54mS | Negative: ~49--63mS |
| Maximum Charge(Microcoulombs per pulse) (if<br>zero, state method of achieving zero net charge<br>for net charge/pulse) | | 2.87uC | 19.64uC (8Hz/500Ω) |
| Maximum Phase Charge(uC) | | 25.86uC | 157.12uC (8Hz/500Ω) |
| Maximum Current Density | | 0.017mA/cm² | 0.26mA/cm² (8Hz/500Ω) |
| Maximum Average Current | | 0.48mA | 2.52mA (8Hz/500Ω) |
| Maximum Average Power Density | | 0.057mW/cm² | 1.33mW/cm² (8Hz/10kΩ) |
| | Pulse per burst | No burst mode | 8~10 pulses |
| Burst Mode | Burst per second | No burst mode | ~1 |
| (i.e. pulse trains) | Burst duration | No burst mode | ~1S |
| | Duty Cycle | No burst mode | 0.25 |
| On Time (Second) | | Constant | Constant |
| Off Time(second) | | Constant | None |
| Additional Features(specify, if applicable) | | NIL | NIL |

- 9. Discussion of Non-Clinical Tests Verification Activities Performed to Determine the Safety and Performance of the devices are as the followings:
Compliance to applicable voluntary standards includes IEC 60601-2-10, as well as IEC 60601-1, and IEC 60601-1-2 requirement. In addition to the compliance of voluntary standards, the software verification has been carried out according to the FDA software guidance.

Discussion: The Compliance to applicable voluntary standards as above mentioned indicates that the new device in this submission used the same standards as that of predicate device. Therefore; we consider that the compliance of standards included in our submission is adequate for the determination of substantial equivalence.

- 10. Discussion of Clinical Test Validation Activities Performed to Determine the Effectiveness of Device are as the followings:
No particular Clinical Test was conducted for Everyway Facial MENS, model MT-200.

- 11. Summary for the technology comparison.
Basically the Everyway Facial MENS, model MT-200 has the similar technological characteristics with the predicate device in the product design, material, energy source type, main program mode and the main output waveform...etc. There exists some difference in the detailed output parameters (mainly in the output intensity and electrode sizes). Through the detailed calculation comparison of stimulation output energy for each operation mode(in particular the output current density and power density), we found the output level in each operation mode for our Everyway Facial MENS, model MT-200 and predicate device are very close and within the acceptable range. So we believe the difference in detailed output parameters does not affect the determination of substantial equivalence.

{6}------------------------------------------------

3F1., No. 5, Lane 155, Sec. 3,Peishen Rd, Shen Keng Hsiang, Taipei Hsien, Taiwan,

#### 12. Conclusions

The Everyway Facial MENS, model MT-200 has the same intended use and the similar technological characteristics as the cleared devices. Moreover, verification and validation tests contained in this submission demonstrate that the difference in the submitted models could maintain the same safety and effectiveness as that of cleared device.

In the other words, those engineering difference do not: (1) affect the intended use or (2) alter the fundamental scientific technology of the device.